Latest news with #CTMA

Montreal Gazette
a day ago
- Business
- Montreal Gazette
Ferry fares in Îles-de-la-Madeleine and Atlantic Canada to be reduced as of Aug. 1
Prime Minister Mark Carney announced Monday that fares for interprovincial ferries and bridge tolls in eastern Quebec and Atlantic Canada will be cut by at least 50 per cent starting Aug. 1. Fulfilling a promise the Liberals made during the April election campaign, Carney said the ferry operating between Îles-de-la-Madeleine and Souris, P.E.I. will see fare cuts by half for passengers, vehicles and commercial traffic. Similar fare reductions will apply to all federally supported ferry services across Atlantic Canada. In addition, the federal government will reduce vehicle tolls on the Confederation Bridge — which links P.E.I. to New Brunswick — from more than $50 to $20. 'Canada's new government is on a mission to bring down costs and build one, strong Canadian economy,' the Prime Minister's Office said Monday in a press release. 'By cutting tolls on the Confederation Bridge and fares on ferries in Atlantic Canada, Canadians and businesses will save millions of dollars. That means more travel and trade between provinces, a stronger, more united economy, and more prosperity and opportunity for Canadians.' The ferry service between Îles-de-la-Madeleine and Souris is operated by the Coopérative de transport maritime et aérien (CTMA). During peak summer season, a one-way ticket currently costs $59.10 for an adult, plus $110.15 for a car. The federal government owns ferry vessels and terminals and leases them to ferry operators, according to the press statement. Annually, more than 531,000 passengers, 200,000 passenger vehicles and nearly 20,000 commercial vehicles use federally owned ferry services in Atlantic Canada. In addition to Îles-de-la-Madeleine and Souris, ferries provide service between Wood Islands in P.E.I., Saint John, N.B., and Caribou and Digby, N.S.
Yahoo
22-05-2025
- Business
- Yahoo
Clinical Trials Matching Software Market Trends Analysis Report 2025-2030: Pharmaceutical and Biotech Firms Lead in Clinical Trials Software Utilization, Web and Cloud Solutions Propel Adoption
Clinical Trials Matching Software Market Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Matching Software Market Size, Share & Trends Analysis Report by Deployment Mode (Web & Cloud-based, on-premise), End Use (Pharmaceutical & Biotechnology Companies, Medical Device Companies), Region, with Growth Forecasts, 2025-2030" report has been added to Clinical Trials Matching Software Market was valued at USD 187.09 Million in 2024, and is projected to reach USD 396.13 Million by 2030, rising at a CAGR of 13.45% The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches. In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in Trials Matching Software Market Report Highlights Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2024 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2024 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities Contract Research Organizations (CRO) segment is expected to register the fastest CAGR over the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective In 2024, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region Asia-Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 120 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $187.09 Million Forecasted Market Value (USD) by 2030 $396.13 Million Compound Annual Growth Rate 13.4% Regions Covered Global Clinical Trials Matching Software Market Variables, Trends & Scope Market Driver Analysis Growing Complexity of Clinical Trials Increasing Demand for Precision Medicine & Personalized Trials Regulatory Push for Enhanced Patient Enrollment Efficiency Rising Investments in Digital Health & Clinical Research Technologies Expanding Clinical Trial Pipelines & Decentralized Trials Partnerships Between Pharma Companies & Tech Firms for Advanced Solutions Market Restraint Analysis High Implementation and Maintenance Costs Data Privacy and Security Concerns Market Opportunities Analysis Clinical Trials Matching Software Market Analysis Tools Industry Analysis - Porter's PESTEL Analysis Emerging Technologies Case Studies & Insights COVID-19 Impact Analysis Companies Featured IBM Antidote Technologies, Inc. Ofni Systems Clario Advarra ArisGlobal BSI Business Systems Integration AG Teckro Limited Evidation Health, Inc. HealthMatch Microsoft Inspirata, Inc. Mendel Health Inc. MatchTrial Curewiki Inteliquet (IQVIA) Tempus Labs For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Clinical Trials Matching Software Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data